Working...
ClinicalTrials.gov
ClinicalTrials.gov Menu

Social Cognition Training and Cognitive Remediation (RCKID)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT03284060
Recruitment Status : Recruiting
First Posted : September 15, 2017
Last Update Posted : April 22, 2019
Sponsor:
Information provided by (Responsible Party):
Hôpital le Vinatier

Brief Summary:

Social cognition refers to mental operations that enable people to perceive, interpret constantly changing social informations. These processes allow people to rapidly, effortlessly and flexibly perceive and interpret rapidly-changing social information, and respond appropriately to social stimuli. Besides, this ability gives meaning to the actions of others. Impairments in this field may largely underlie social dysfunctions and reduce adaptive skills. Moreover, social cognitive disabilities contribute more or less directly to behavioral disturbances and psychiatric symptoms The "RC KID" program involves a variety of exercises in a paper and/or pencil or a computerized format or role playing and a strategy coaching approach. "RC KID" targets the emotion recognition and social interaction.

A little cartoon character (a pirate), is supposed to be very friendly and kind toward children. The pirate will accompany them throughout the program for an effective and positive reinforcement. The main goal of "RC KID" is to adjust to children's difficulties in daily life.

Moreover, since the cognitive remediation benefit is complex to apply in daily life, the program is based on a metacognitive strategy.

After a complete neuropsychological assessment and a psychoeducational session (with the child and the parents), 16 1-h-sessions of cognitive remediation with the therapist are proposed. Each session is composed of three parts: (1) computerized tasks focusing on specific emotion recognition components (20 min). RC KID is composed of 2 modules : Emotion recognition and social interaction. These tasks contain photo or video. (2) pen and paper or role playing tasks focusing on the same processes (20 min) (3) a proposal of a home-based task (during 20 min). Weekly, home tasks are proposed to the child and analyzed with the parents and the therapist. Indeed, home exercises are useful to promote the transfer of strategies to daily life and their subsequent automation. The heterogeneity of cognitive deficits in 22q11.2 deletion necessitates an individualized cognitive remediation therapy. In this regard, "RC KID" seems to be a promising tool.


Condition or disease Intervention/treatment Phase
22q11.2 Deletion Syndrome Behavioral: Cognitive remediation program Not Applicable

Detailed Description:

The second objective is to evaluate the impact of RC KID on behavior disorders. Method : a validation study using multiple single-case experimental designs. A thorough assessment, including a complete evaluation of components of social cognition but also clinical and neuropsychological assessments is proposed for each patient enrolled in the study.

Investigators collect three kinds of baselines before the beginning of the cognitive remediation intervention: baselines specific of the targeted component (Emotion recognition and Theory of Mind), non-specific baselines (such as measures of neurocognition processes that should not be affected by the intervention), and intermediary baselines that is measures of social cognitive function linked with targeted processes but not directly concerned by the cognitive remediation program.

These measures and the complete assessment will be repeated at the end of the intervention to highlight impacts of RC KID on social cognitive impairments, and 6 months later to investigate the possible long-lasting effects of the benefits.


Layout table for study information
Study Type : Interventional  (Clinical Trial)
Estimated Enrollment : 10 participants
Intervention Model: Single Group Assignment
Intervention Model Description: open Label
Masking: None (Open Label)
Primary Purpose: Treatment
Official Title: Social Cognition Training and Cognitive Remediation : a New Tool for 22q11.2 Deletion Syndrome
Actual Study Start Date : October 11, 2017
Estimated Primary Completion Date : October 15, 2019
Estimated Study Completion Date : April 15, 2020


Arm Intervention/treatment
Experimental: Cognitive remediation program Behavioral: Cognitive remediation program

Cognitive remediation program is a set of reeducation techniques and aims at restoring or compensating altered cognitive functions such as memory, attentional or executive functions, and social cognition. Therapists help individuals develop new information processing strategies designed to meet their needs and wishes. Specific therapeutic sessions are designed to generalize such strategies to everyday situations to reduce the impact of cognitive deficits on daily life. Thus, social cognitive training therapy helps the development of personal strategies specifically adapted to preserve skills and reduce the difficulties.

16 sessions (45 min) of cognitive remediation with the therapist are proposed, each session is composed of three parts:

  1. pen and paper tasks focusing on specific emotion recognition component (20 min),
  2. computerized tasks focusing on the same process (20 min),
  3. a proposal of a home-based task (during 20 min).




Primary Outcome Measures :
  1. The primary endpoint is the variation in sub-scores of specific baselines, obtained before and after cognitive remediation intervention: [ Time Frame: 6 months ]

    baselines specific of the targeted component (Emotion recognition and Theory of Mind), non-specific baselines (such as measures of neurocognition processes that should not be affected by the intervention), intermediary baselines that is measures of social cognitive function linked with targeted processes but not directly concerned by the cognitive remediation program.

    These measure is repeated at the end of the intervention to highlight the impact of the " RCKID " program, and 6 months later to investigate the possible long-lasting effects of the benefits



Secondary Outcome Measures :
  1. Aberrant Behavior Checklist scale [ Time Frame: 6 months ]
    Change in sub-score " hyperactivity / non compliance " (scale " Aberrant Behavior Checklist ") (completed by parents or the educational team). This measure is repeated at the end of the intervention to highlight the impact of the " RC KID " program, and 6 months later to investigate the possible long-lasting effects of the benefits.

  2. MDI-C scale ( Multiscore Depression Inventory for Children scale) [ Time Frame: 6 months ]
  3. KIDSCREEN-27 scale [ Time Frame: 6 months ]
    The KIDSCREEN-27 with five dimensions resulted. All five dimensions are Rasch scales: Physical Well-Being (5 items), Psychological Well-Being (7 items), Autonomy & Parents (7 items), Peers & Social Support (4 items), and School Environment (4 items).

  4. Vineland 2 scale (Vineland Adaptive Behavior Scale) [ Time Frame: 6 months ]
    A measure of adaptive behavior from birth to adulthood



Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   5 Years to 13 Years   (Child)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • Children with diagnosis of 22q11.2 deletion syndrome (CGH-Array and FISH)
  • Native French speaker
  • Clinically stable
  • Parental and children consent

Exclusion Criteria:

  • history of neurological illness or trauma
  • Taking of medicine with somatic aim having a cerebral or psychic impact
  • Simultaneous participation on another program of cognitive remediation
  • child or parents unlikely to cooperate

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03284060


Contacts
Layout table for location contacts
Contact: DEMILY CAROLINE, PH 00334 37 91 51 63 caroline.demily@ch-le-vinatier.fr
Contact: MOREL Aurore 00334 37 91 51 63 aurore.morel@ch-le-vinatier.fr

Locations
Layout table for location information
France
Hopital Vinatier Recruiting
Lyon, Rhone Alpes, France, 69678
Contact: DEMILY MD CAROLINE, PH    0033437915163    caroline.demily@ch-le-vinatier.fr   
Contact: VIAL VERONIQUE    0033437915531    veronique.vial@ch-le-vinatier.fr   
Sponsors and Collaborators
Hôpital le Vinatier
Investigators
Layout table for investigator information
Principal Investigator: DEMILY CAROLINE, PH CENTRE HOSPITALIER LE VINATIER

Layout table for additonal information
Responsible Party: Hôpital le Vinatier
ClinicalTrials.gov Identifier: NCT03284060     History of Changes
Other Study ID Numbers: 2017-A00881-52
First Posted: September 15, 2017    Key Record Dates
Last Update Posted: April 22, 2019
Last Verified: April 2019
Individual Participant Data (IPD) Sharing Statement:
Plan to Share IPD: No

Layout table for additional information
Studies a U.S. FDA-regulated Drug Product: No
Studies a U.S. FDA-regulated Device Product: No

Keywords provided by Hôpital le Vinatier:
Cognitive remediation, 22q11.2 deletion syndrome

Additional relevant MeSH terms:
Layout table for MeSH terms
DiGeorge Syndrome
Craniosynostoses
Marfan Syndrome
Arachnodactyly
Syndrome
Disease
Pathologic Processes
22q11 Deletion Syndrome
Craniofacial Abnormalities
Musculoskeletal Abnormalities
Musculoskeletal Diseases
Heart Defects, Congenital
Cardiovascular Abnormalities
Cardiovascular Diseases
Heart Diseases
Lymphatic Abnormalities
Lymphatic Diseases
Abnormalities, Multiple
Congenital Abnormalities
Chromosome Disorders
Genetic Diseases, Inborn
Hypoparathyroidism
Parathyroid Diseases
Endocrine System Diseases
Synostosis
Dysostoses
Bone Diseases, Developmental
Bone Diseases
Connective Tissue Diseases
Limb Deformities, Congenital